Fundraising Fox
Novellus Ventures Ls1 Gp, Llc
Venture capitalActively deployingHouston · Pre-Seed–Series A · 6 people tracked
Find your way into Novellus Ventures Ls1 Gp, Llc
Sign up to see every warm intro you have to Novellus Ventures Ls1 Gp, Llc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novellus Ventures Ls1 Gp, Llc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Novellus Ventures invests at the early stage in companies transforming healthcare, focusing on diagnostics, med-tech, therapeutics, and digital health that improve how disease is detected, treated, and prevented. The firm evaluates a company's product roadmap, clinical validation plan, regulatory approach, and commercial entry strategy using scientific rigor, operational experience, and a deep clinical network. Its philosophy centers on disciplined evaluation, high-conviction backing, and long-term partnership. Beyond capital, Novellus offers strategic support on regulatory and clinical development pathways and go-to-market execution, curated network access to experts and advisors, operational insight from entrepreneurial experience, and patient long-term partnership through a company's growth.
Source: firm website, verified Oct 13, 2026.
Team · 6 people
from the firm's websiteFounder and Managing Partner of Novellus Ventures, a technology entrepreneur and investor with over 30 years across software, energy, and life sciences, with a track record of building and scaling companies from inception to acquisition.
Biotech entrepreneur and translational leader with 30+ years across global pharma and startups, including roles at Sanofi and GSK, and founder/CEO of oncology-focused therapeutics companies.
PharmD and venture associate at the Houston Angel Network who has evaluated 100+ early-stage life-science startups; Lead Navigator at First Flight Venture Center and founder of Venture Weavers Consulting.
Infectious disease physician and Medical Director at UnitedHealth Group advising on regulatory pathways and adoption of life-sciences technologies, with training in data science and clinical trial design.
Assistant Professor of Neurology, Neurosurgery, and Space Medicine at BCM and a clinician specializing in severe brain injury and neurological emergencies. Serves as clinical advisor to the Translational Research Institute for Space Health with 60+ peer-reviewed publications and patents.
Clinical translation and venture professional with expertise across regulatory, reimbursement, commercial, and IP strategy; former Venture Associate at Houston Angel Network and mentor across TMC Innovation, Rice University, Nucleate Texas, and Startup Prize.
Frequently asked questions
- What stage does Novellus Ventures Ls1 Gp, Llc invest at?
- Novellus Ventures Ls1 Gp, Llc invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Novellus Ventures Ls1 Gp, Llc focus on?
- Novellus Ventures Ls1 Gp, Llc focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Novellus Ventures Ls1 Gp, Llc located?
- Novellus Ventures Ls1 Gp, Llc is headquartered in Houston, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.